Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

Promoting remyelination, a major goal of an effective treatment for demyelinating diseases, has the potential to protect vulnerable axons, increase conduction velocity, and improve neurologic deficits. Strategies to promote remyelination have focused on transplanting oligodendrocytes (OLs) or recrui...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Warrington, Arthur E., Asakura, Kunihiko, Bieber, Allan J., Ciric, Bogoljub, Van Keulen, Virginia, Kaveri, Srini V., Kyle, Robert A., Pease, Larry R., Rodriguez, Moses
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 2000
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC18751/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10841576/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.97.12.6820
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!